Evidence map›Paper›PMID 31323092›Full record

ArticleThe Journal of infectious diseases2019

Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.

Rose Nabatanzi, Lois Bayigga, Stephen Cose, Sarah Rowland Jones, Moses Joloba, Glenda Canderan, Damalie Nakanjako

Open access · hybridAbstract readComparative Study
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 31 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Frontiers in cellular and infection microbiology · 2020
    Article
  20. Conventional Dendritic Cells and SlanFrontiers in immunology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Rose NabatanziDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Lois BayiggaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Stephen CoseMedical Research Council/Uganda Virus Research Institute, Uganda Research Unit on AIDS, Entebbe, Uganda.
Sarah Rowland JonesNuffield Department of Medicine, University of Oxford, United Kingdom.
Moses JolobaDepartment of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda.
Glenda CanderanDepartment of Pathology, Case Western Reserve University, Cleveland, Ohio.
Damalie NakanjakoDepartment of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Makerere University · UGCase Western Reserve University · USUganda Virus Research Institute · UGUniversity of Oxford · GB

Funding

Wellcome Trust 107743/Z/15/Z
6 · The paper itself

Abstract

backgroundMonocyte dysfunction may persist during antiretroviral therapy (ART).

methodsFrozen peripheral blood mononuclear cells of 30 human immunodeficiency virus (HIV)-infected ART-treated adults with sustained viral suppression and CD4 counts ≥500 cells/µL were consecutively analyzed for monocyte phenotypes and function.

resultsNonclassical monocytes (CD14+, CD16++), interleukin (IL)-1β production, and expression of CD40 and CD86 were lower among ART-treated HIV-infected adults relative to age-matched HIV-negative adults (P = .01, P = .01, and P = .02, respectively). Intestinal fatty acid-binding protein, IL6, and soluble CD14 were higher among HIV-infected adults relative to HIV-negative adults (P = .0002, P = .04, and P = .0017, respectively).

conclusionsFurther investigation is required to understand drivers of persistent monocyte activation and dysfunction.

Indexed as

Sustained Virologic ResponseAdolescentAdultAfricaAgedAged, 80 and overAntigens, CDAnti-Retroviral AgentsCross-Sectional StudiesFemaleHIV InfectionsHumansImmunophenotypingInflammationMaleMiddle AgedAntigens, CDAnti-Retroviral AgentsHIV infectionimmune activationimmune responseslong-term antiretroviral therapysub-Saharan Africa

Identifiers

PMID31323092
PMCPMC6761975
OpenAlexW2962845579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.